a multicenter trial on the efficacy and tolerability of ofloxacin in upper and lower respiratory tract infections and urinary tract infections was carried out on 1,436 patients ( 926 males and 510 females ; mean age 55.9 +/- 18.4 years ) .
C0028902
ofloxacin
C0042029
urinary tract infections